Advertisement
Advertisement
U.S. Markets open in 6 hrs 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Eton Pharmaceuticals, Inc. (ETON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
3.1900-0.0600 (-1.85%)
At close: 04:00PM EST
3.3000 +0.11 (+3.45%)
After hours: 07:46PM EST
Advertisement

Eton Pharmaceuticals, Inc.

21925 West Field Parkway
Suite 235
Deer Park, IL 60010-7208
United States
847 787 7361
https://www.etonpharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees17

Key Executives

NameTitlePayExercisedYear Born
Mr. Sean E. BrynjelsenPres, CEO & Director692.12kN/A1972
Mr. James R. Gruber CPACFO, Treasurer & Sec.N/AN/A1972
Mr. David KrempaSr. VP of Bus. Devel. & Investor RelationsN/AN/AN/A
Ms. Ingrid HoosSr. VP of Regulatory AffairsN/AN/AN/A
Mr. Kevin GuthrieExec. VP of Commercial OperationsN/AN/AN/A
Mr. Scott GrossenbachVP of Sales & MarketingN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Corporate Governance

Eton Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement